Veraxa-News-December
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline Zurich, 29th of December 2023: VERAXA Biotech AG, a pioneering company in the development of
August 8, 2024
No Comments
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline Zurich, 29th of December 2023: VERAXA Biotech AG, a pioneering company in the development of
Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for
Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector Abu Dhabi, United Arab